The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Ellen Miller Sonet named chief strategy and alliance officer of CancerCare

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

ELLEN MILLER SONET was named chief strategy and alliance officer of CancerCare.

Sonet will serve on the nonprofit’s executive leadership team. She previously served for nearly 17 years as vice president of marketing at Memorial Sloan-Kettering Cancer Center.

Prior to her tenure at Memorial Sloan-Kettering, Sonet worked in pharmaceutical marketing on brands such as Afrin Nasal Spray and Bayer Aspirin.

YOU MAY BE INTERESTED IN

AACR Cancer Progress Report makes the case for federal investment in cancer research

As NCI and NIH funding is being deliberated in Congress, this year’s 2025 AACR Cancer Progress Report had an unequivocal message: With 20 new anticancer therapeutics, new uses for eight previously approved anticancer therapeutics, two new early detection tools, and several AI-powered diagnostics approved over the span of just one year, cancer research funding yields a good return on investment. 
By Sara Willa Ernst

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account